TY - JOUR
T1 - MTHFR, MTR and MTRR polymorphisms and risk of chronic kidney disease in Japanese
T2 - Cross-sectional data from the J-MICC Study
AU - Hishida, Asahi
AU - Okada, Rieko
AU - Guang, Yin
AU - Naito, Mariko
AU - Wakai, Kenji
AU - Hosono, Satoyo
AU - Nakamura, Kazuyo
AU - Turin, Tanvir Chowdhury
AU - Suzuki, Sadao
AU - Niimura, Hideshi
AU - Mikami, Haruo
AU - Otonari, Jun
AU - Kuriyama, Nagato
AU - Katsuura, Sakurako
AU - Kubo, Michiaki
AU - Tanaka, Hideo
AU - Hamajima, Nobuyuki
N1 - Funding Information:
Acknowledgments The authors wish to thank Mr. Kyota Ashikawa and Ms. Tomomi Aoi at the Laboratory of Genotyping Development, Center for Genomic Medicine, RIKEN, for genotyping. The authors also thank Ms. Yoko Mitsuda and Ms. Keiko Shibata at Daiko Medical Center, Nagoya University, for their technical assistance. This study was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas of Cancer (No. 17015018) and Scientific Support Programs for Cancer Research, and Grant-in-Aid for Scientific Research on Innovative Areas (No. 221S0001) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.
PY - 2013/12
Y1 - 2013/12
N2 - Purpose: Chronic kidney disease (CKD) is well known as a strong risk factor for both of end-stage renal disease and cardiovascular disease. To clarify the associations of MTHFR, MTR, and MTRR polymorphisms with the risk of CKD in Japanese, we examined this association among Japanese subjects using cross-sectional data. Methods: The subjects for this analysis were 3,318 participants consecutively selected from the Japan Multi-institutional Collaborative Cohort (J-MICC) Study. The polymorphisms were genotyped by a multiplex polymerase chain reaction-based Invader assay. Age- and sex-adjusted odds ratio (aOR) of CKD with stage 3-5 was calculated for each genotype. Results: When those with MTHFR C677T C/C were defined as references, those with MTHFR C677T C/T and T/T demonstrated the aORs for CKD of 1.14 (95 % CI 0.93-1.40) and 1.39 (1.06-1.82), respectively. Marginally significantly decreased risk of CKD with increasing number of MTR A2756G G allele (p = 0.058) was observed. Stratified analyses by plasma folate low (<7.4 ng/ml) or high (≥7.4 ng/ml) suggested significantly higher OR of CKD for those with MTHFR C677T T/T and low serum folate with the aOR of 2.07 (95 % CI 1.30-3.31) compared with that for those with MTHFR C677T T/T and high serum folate. Conclusions: The present study found a significant association between the subjects with the T/T genotype of MTHFR C677T polymorphism and the elevated risk of CKD, which may suggest the possibility of the risk evaluation and prevention of this potentially life-threatening disease based on genetic traits in the near future.
AB - Purpose: Chronic kidney disease (CKD) is well known as a strong risk factor for both of end-stage renal disease and cardiovascular disease. To clarify the associations of MTHFR, MTR, and MTRR polymorphisms with the risk of CKD in Japanese, we examined this association among Japanese subjects using cross-sectional data. Methods: The subjects for this analysis were 3,318 participants consecutively selected from the Japan Multi-institutional Collaborative Cohort (J-MICC) Study. The polymorphisms were genotyped by a multiplex polymerase chain reaction-based Invader assay. Age- and sex-adjusted odds ratio (aOR) of CKD with stage 3-5 was calculated for each genotype. Results: When those with MTHFR C677T C/C were defined as references, those with MTHFR C677T C/T and T/T demonstrated the aORs for CKD of 1.14 (95 % CI 0.93-1.40) and 1.39 (1.06-1.82), respectively. Marginally significantly decreased risk of CKD with increasing number of MTR A2756G G allele (p = 0.058) was observed. Stratified analyses by plasma folate low (<7.4 ng/ml) or high (≥7.4 ng/ml) suggested significantly higher OR of CKD for those with MTHFR C677T T/T and low serum folate with the aOR of 2.07 (95 % CI 1.30-3.31) compared with that for those with MTHFR C677T T/T and high serum folate. Conclusions: The present study found a significant association between the subjects with the T/T genotype of MTHFR C677T polymorphism and the elevated risk of CKD, which may suggest the possibility of the risk evaluation and prevention of this potentially life-threatening disease based on genetic traits in the near future.
UR - http://www.scopus.com/inward/record.url?scp=84890803951&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84890803951&partnerID=8YFLogxK
U2 - 10.1007/s11255-013-0432-0
DO - 10.1007/s11255-013-0432-0
M3 - Article
C2 - 23595572
AN - SCOPUS:84890803951
SN - 0301-1623
VL - 45
SP - 1613
EP - 1620
JO - International Urology and Nephrology
JF - International Urology and Nephrology
IS - 6
ER -
